Shopping Cart 0
Cart Subtotal
AED 0

Disruptor Profile: Pear Therapeutics, Inc.

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 1285

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 2569

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 3854

Details

Disruptor Profile: Pear Therapeutics, Inc.

Summary

The report provides information and insights into Pear Therapeutics, Inc.'s, including -

- Overview of the company and its product offering

- Detailed insight into its business model, company type and headquarter

- Information on partnership and funding

- Biography of top management.

Scope

- Pear Therapeutics Inc. (Pear) is a pioneer in software-based prescription digital therapeutics (PDT) for the treatment of severe diseases and serious medical conditions.

Reasons to buy

- Gain insights into Pears's business operations.

- Gain insights into funding and partnerships

- Gain understanding about its technology focus.

READ MORE

Table Of Content

Scope

Table of contents

Company Overview

Technology Focus

Product Overview

Partnerships & Funding

Key Employees

Appendix

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Mobile, Software-based prescription digital therapeutics, Software-enabled treatment


Companies

Sandoz

Novartis

EDBI Pte Ltd

Blue Water Life Science Fund LP

Bridge Builders Collaborative

5AM Venture Management LLC

Novartis AG

TrustBridge Partners

Arboretum Ventures LLC

Temasek Holdings (Private) Ltd

JAZZ Venture Partners L.P.

Disruptor Profile: Pear Therapeutics, Inc.

Summary

The report provides information and insights into Pear Therapeutics, Inc.'s, including -

- Overview of the company and its product offering

- Detailed insight into its business model, company type and headquarter

- Information on partnership and funding

- Biography of top management.

Scope

- Pear Therapeutics Inc. (Pear) is a pioneer in software-based prescription digital therapeutics (PDT) for the treatment of severe diseases and serious medical conditions.

Reasons to buy

- Gain insights into Pears's business operations.

- Gain insights into funding and partnerships

- Gain understanding about its technology focus.

READ MORE

Scope

Table of contents

Company Overview

Technology Focus

Product Overview

Partnerships & Funding

Key Employees

Appendix

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Mobile, Software-based prescription digital therapeutics, Software-enabled treatment


Companies

Sandoz

Novartis

EDBI Pte Ltd

Blue Water Life Science Fund LP

Bridge Builders Collaborative

5AM Venture Management LLC

Novartis AG

TrustBridge Partners

Arboretum Ventures LLC

Temasek Holdings (Private) Ltd

JAZZ Venture Partners L.P.